These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24067853)

  • 1. Mycophenolic acid for lymphomatoid papulosis.
    Champagne T; Walsh S
    J Cutan Med Surg; 2013; 17(5):332-4. PubMed ID: 24067853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lymphomatoid papulosis in a 2 1/2-year-old boy].
    Amann PM; Megahed M
    Hautarzt; 2011 Nov; 62(11):807-9. PubMed ID: 22037883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type A lymphomatoid papulosis presenting as an eyelid ulcer in a young man.
    Sánchez España JC; Secondi R
    Orbit; 2019 Dec; 38(6):495-499. PubMed ID: 30644803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical methotrexate for lymphomatoid papulosis.
    Bergstrom JS; Jaworsky C
    J Am Acad Dermatol; 2003 Nov; 49(5):937-9. PubMed ID: 14576686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders.
    Vonderheid EC; Sajjadian A; Kadin ME
    J Am Acad Dermatol; 1996 Mar; 34(3):470-81. PubMed ID: 8609262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphomatoid papulosis associated with recurrent cutaneous T-cell lymphoma.
    Tan AW; Giam YC
    Ann Acad Med Singap; 2004 Jan; 33(1):110-2. PubMed ID: 15008576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis.
    Duvic M; Tetzlaff MT; Gangar P; Clos AL; Sui D; Talpur R
    J Clin Oncol; 2015 Nov; 33(32):3759-65. PubMed ID: 26261247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphomatoid papulosis: A cutaneous lymphoproliferative disorder in a patient on fingolimod for multiple sclerosis.
    Samaraweera AP; Cohen SN; Akay EM; Evangelou N
    Mult Scler; 2016 Jan; 22(1):122-4. PubMed ID: 26219664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic use of interferon-alpha for lymphomatoid papulosis.
    Schmuth M; Topar G; Illersperger B; Kowald E; Fritsch PO; Sepp NT
    Cancer; 2000 Oct; 89(7):1603-10. PubMed ID: 11013377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neutrophil-rich, anaplastic CD30+ T cell lymphoma in conjunction with lymphomatoid papulosis].
    Slotosch CM; Hörster S; Hertl M; Schultz E
    Hautarzt; 2010 Jun; 61(6):511-3. PubMed ID: 19536511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphomatoid papulosis.
    Wiznia LE; Cohen JM; Beasley JM; Meehan SA; Latkowski JM
    Dermatol Online J; 2018 Dec; 24(12):. PubMed ID: 30677799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of lymphomatoid papulosis with photodynamic therapy.
    Rodrigues M; McCormack C; Yap LM; Prince HM; Roberts H; Williams R; Foley P
    Australas J Dermatol; 2009 May; 50(2):129-32. PubMed ID: 19397568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unusual case of lymphomatoid papulosis type E with extensive necrosis.
    Pindado-Ortega C; Fonda-Pascual P; Buendía-Castaño D; Fernández-González P; Peña-Jaimes L; Carrillo-Gijón R
    Indian J Dermatol Venereol Leprol; 2018; 84(4):515-517. PubMed ID: 29067932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphomatoid papulosis type D or an aggressive epidermotropic CD8(+) cytotoxic T-cell lymphoma?
    Andersen RM; Larsen MS; Poulsen TS; Lauritzen AF; Skov L
    Acta Derm Venereol; 2014 Jul; 94(4):474-5. PubMed ID: 24217891
    [No Abstract]   [Full Text] [Related]  

  • 15. [Oral involvement in lymphomatoid papulosis].
    Serra-Guillén C; Requena C; Alfaro A; Hueso L; Sanmartín O; Llombart B; Nagore E; Botella-Estrada R; Martorell-Calatayud A; Guillén C
    Actas Dermosifiliogr; 2007 May; 98(4):265-7. PubMed ID: 17506958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large cell transformation mimicking regional lymphomatoid papulosis in a patient with mycosis fungoides.
    Nakahigashi K; Ishida Y; Matsumura Y; Kore-Eda S; Ohmori K; Fujimoto M; Yamashita K; Kotani H; Sakurai T; Miyachi Y
    J Dermatol; 2008 May; 35(5):283-8. PubMed ID: 18477228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphomatoid Papulosis With a Unique T Follicular Helper-Like Phenotype.
    Tran J; Duvic M; Torres-Cabala CA
    Am J Dermatopathol; 2020 Oct; 42(10):776-779. PubMed ID: 32568843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary ALK negative anaplastic large cell lymphoma in a patient with lymphomatoid papulosis of 40 years duration.
    Marschalkó M; Eros N; Holló P; Hársing J; Bottlik G; Bátai A; Csukly Z; Masszi T; Szentirmai Z; Fodor J; Kárpáti S; Matolcsy A; Csomor J
    Am J Dermatopathol; 2010 Oct; 32(7):708-12. PubMed ID: 20644462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphomatoid papulosis: Treatment response and associated lymphomas in a study of 180 patients.
    Wieser I; Oh CW; Talpur R; Duvic M
    J Am Acad Dermatol; 2016 Jan; 74(1):59-67. PubMed ID: 26518172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphomatoid papulosis with associated cerebellar lesion of similar histology and T-cell clonality.
    McKay C; Nelson A; Sugo E; Cohn R; Wargon O
    Australas J Dermatol; 2014 Nov; 55(4):e60-4. PubMed ID: 23713913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.